Dr Jennifer Devlin
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
22 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Abstract LB476: Combined inhibition of transcription initiation and histone deacetylation triggers blood cancer cell death
DOI: 10.1158/1538-7445.am2026-lb4762025
Journal article
A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation
DOI: 10.1016/j.molcel.2025.08.0012024
Journal article
Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling
DOI: 10.1111/febs.171962022
Journal article
Targeting transcription cycles in cancer
DOI: 10.1038/s41568-021-00411-82021
Journal article
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
DOI: 10.1016/j.cell.2021.04.0222021
Journal article
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
DOI: 10.1016/j.molcel.2021.04.0152021
Journal article
Serine biosynthesis is a metabolic vulnerability in flt3-itd–driven acute myeloid leukemia
DOI: 10.1158/2159-8290.CD-20-0738
RECENT SCHOLARLY WORKS
2020
Journal article
Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis
DOI: 10.15252/embj.20201051112020
Journal article
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies
DOI: 10.1038/s41375-019-0652-02020
Journal article
CDK13 cooperates with CDK12 to control global RNA polymerase II processivity
DOI: 10.1126/sciadv.aaz5041